Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer.

导出 OA

翻译打印收藏纠错

作者： Pernelle,Lavaud ^[1] ; Clément,Dumont ^[2] ; Constance,Thibault ^[3] ; Laurence,Albiges ^[1] ; Giulia,Baciarello ^[1] ; Emeline,Colomba ^[1] ; Ronan,Flippot ^[1] ; Alina,Fuerea ^[1] ; Yohann,Loriot ^[1] ; Karim,Fizazi ^[4]

作者单位： Department of Cancer Medicine, Gustave Roussy Cancer Campus, University of Paris Saclay, Villejuif, France. ^[1] Department of Cancer Medicine, Hôpital Saint Louis, Paris, France. ^[2] Department of Medical Oncology, Hôpital Européen Georges-Pompidou, Paris, France. ^[3] Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, 114 Rue Edouard Vaillant, Villejuif, 94805, France. ^[4]

关键词 apalutamide castration resistance darolutamide enzalutamide next generation androgen receptor inhibitors non-metastatic setting prostate cancer

DOI 10.1177/1758835920978134

PMID 33488778

发布时间 2021-01-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in medical oncology

2020年12卷

1758835920978134页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer.

Therapeutic advances in medical oncology

相似文献

Therapeutic advances in medical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer.

Therapeutic advances in medical oncology

相似文献

Therapeutic advances in medical oncology

相关期刊

检索历史清除